RGT
Click for more information
0.00% 29.0¢ argent biopharma limited

Out of MXC MMJ and AC8 ... who is likely to start making $...

  1. Brownie79
    152 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    10/03/17
    09:20
    Post #: 23239775
    Out of MXC MMJ and AC8 ... who is likely to start making $ decent profits first?

    Bought in yesterday, birthday today ... if for some funny reason SP comes down at all I'll just have to top up for a birthday present.

    Very exciting times !!!

    With big hedge funds in the US investing in Medical Marijuana companies, our Aussie companies can only grow and go gang busters. Hold onto your seats. GLTA

    DYOR

    Brownie
    MXC Price at posting: 6.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
AWJ Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance
right-arrow Created with Sketch.
SXE SCEE boosts Synergy deal by $50M for Collie battery project
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
ITM Fast-track assaying yields 182 g/t gold for iTech at new NT play
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
29.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $13.31M
Open High Low Value Volume
29.0¢ 29.0¢ 29.0¢ $22 75

Buyers (Bids)

No. Vol. Price($)
5 6566 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 44617 1
View Market Depth
Last trade - 12.25pm 05/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.